Phase I trial of BI 1147560 for the treatment and prevention of Alzheimer's disease
Latest Information Update: 07 Apr 2015
At a glance
- Drugs BI 1181181 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
Most Recent Events
- 07 Apr 2015 New trial record